Ambryx Biotechnology, Inc.
Records under this name other than patents Ambryx Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Ambryx Biotechnology, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,528,108 | Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments Lapsed on the fee record Ended May 5, 2021 · USPTO record | Lapsed on the fee record | Ended May 5, 2021 | USPTO record |
| US 6,258,779 | Method of using fetuin to induce apoptosis in cancer cells Term ended Term ended Oct 7, 2019 · USPTO record | Term ended | Term ended Oct 7, 2019 | USPTO record |
| US 7,445,784 | Polypeptide for the treatment of cancer and a method for preparation thereof Lapsed on the fee record Ended Nov 4, 2016 · USPTO record | Lapsed on the fee record | Ended Nov 4, 2016 | USPTO record |
| US 8,247,380 | Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines Lapsed on the fee record Ended Aug 21, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 21, 2016 | USPTO record |
| US 6,737,402 | Method of preparing fetuin to induce apoptosis Lapsed on the fee record Ended May 18, 2016 · USPTO record | Lapsed on the fee record | Ended May 18, 2016 | USPTO record |
| US 6,720,311 | Polypeptide for the treatment of cancer and a method for preparation thereof Lapsed on the fee record Ended Apr 13, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 13, 2016 | USPTO record |
| US 7,344,721 | Polypeptide for the treatment of cancer and a method for preparation thereof Lapsed on the fee record Ended Mar 18, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 18, 2016 | USPTO record |
| US 7,341,724 | Polypeptide for the treatment of cancer and a method for preparation thereof Lapsed on the fee record Ended Mar 11, 2016 · USPTO record | Lapsed on the fee record | Ended Mar 11, 2016 | USPTO record |
| US 7,238,662 | Alpha 2HS glycoprotein for treatment of cancer and a method for preparation thereof Lapsed on the fee record Ended Jul 3, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2015 | USPTO record |
| US 7,193,040 | Polypeptide for the treatment of cancer and a method for preparation thereof Lapsed on the fee record Ended Mar 20, 2015 · USPTO record | Lapsed on the fee record | Ended Mar 20, 2015 | USPTO record |